Снимка 1: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 2: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 3: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 4: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 5: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 6: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 7: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 8: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 9: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 10: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 11: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 12: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 13: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 14: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 15: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 16: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 17: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 18: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 19: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 20: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 21: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 22: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 23: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 24: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 25: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 26: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 27: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 28: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 29: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 30: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 31: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 32: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 33: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 34: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 35: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 36: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 37: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 38: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 39: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 40: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 41: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 42: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 43: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 44: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 45: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 46: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 47: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 48: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Снимка 49: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
/2 страници